Brief: Glaukos Q4 Sales USD 105.5 Million Vs. IBES Estimate USD 100.7 Million
Feb 20 (Reuters) - Glaukos Q4 gross margin 73%. * Q4 adjusted net income USD -22.2 million vs. IBES estimate USD -20.8 million * Q4 net income USD -33.6 million * Q4 adjusted gross margin 82% * outlook FY sales USD 475-485 million
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary